112 related articles for article (PubMed ID: 16294944)
21. Delayed multiple injection site reaction in a rheumatoid arthritis patient treated with etanercept.
Rajakulendran S; Deighton C
Rheumatology (Oxford); 2004 Dec; 43(12):1588-9. PubMed ID: 15564639
[No Abstract] [Full Text] [Related]
22. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy.
Davison SC; Bunker CB; Basarab T
Br J Dermatol; 2002 Oct; 147(4):831-2; author reply 832. PubMed ID: 12366452
[No Abstract] [Full Text] [Related]
23. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
24. Etanercept-associated injection-site reactions.
Murphy FT; Enzenauer RJ; Battafarano DF; David-Bajar K
Arch Dermatol; 2000 Apr; 136(4):556-7. PubMed ID: 10768663
[No Abstract] [Full Text] [Related]
25. Bioequivalence of liquid and reconstituted lyophilized etanercept subcutaneous injections.
Sullivan JT; Ni L; Sheelo C; Salfi M; Peloso PM
J Clin Pharmacol; 2006 Jun; 46(6):654-61. PubMed ID: 16707412
[TBL] [Abstract][Full Text] [Related]
26. Marked hypertriglyceridemia upon treatment with etanercept.
Haroon M; Devlin J
Joint Bone Spine; 2009 Oct; 76(5):570-1. PubMed ID: 19303341
[No Abstract] [Full Text] [Related]
27. Intraarticular injection of anti-tumor necrosis factor: Comment on the letter by Arnold et al.
Bliddal H
Arthritis Rheum; 2004 Jun; 50(6):2037-8. PubMed ID: 15188385
[No Abstract] [Full Text] [Related]
28. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis.
Kowalzick L; Bertolini J; Baumann C; Walther B; Truhm B; Eickenscheidt L
J Dtsch Dermatol Ges; 2013 May; 11(5):447-9. PubMed ID: 23343137
[No Abstract] [Full Text] [Related]
29. Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: a relevant class-effect.
Garcovich S; Burlando M; Rongioletti F; Garcovich A; Parodi A; Amerio P
Acta Derm Venereol; 2010 May; 90(3):311-2. PubMed ID: 20526559
[No Abstract] [Full Text] [Related]
30. A case of eczematous and vesicular dermatitis during anti-TNFalpha therapy for rheumatoid arthritis.
Savoia F; Gaddoni G; Casadio C; Spadola G; Patrizi A; Giacomini F; Aldi M
G Ital Dermatol Venereol; 2011 Aug; 146(4):308-9. PubMed ID: 21785399
[No Abstract] [Full Text] [Related]
31. Granulomatous lung disease occurring during etanercept treatment.
Phillips K; Weinblatt M
Arthritis Rheum; 2005 Aug; 53(4):618-20. PubMed ID: 16082636
[No Abstract] [Full Text] [Related]
32. Digital vasculitis with eosinophilia possibly associated with etanercept therapy.
Nakahigashi K; Egawa G; Miyachi Y; Kabashima K
Acta Derm Venereol; 2014 Mar; 94(2):239-40. PubMed ID: 23824408
[No Abstract] [Full Text] [Related]
33. Nicolau syndrome following etanercept administration.
Guarneri C; Polimeni G
Am J Clin Dermatol; 2010; 11 Suppl 1():51-2. PubMed ID: 20586511
[TBL] [Abstract][Full Text] [Related]
34. Staphylococcus aureus sepsis after etanercept induction in a hemodialysis patient.
Ikumi N; Matsukawa Y; Kuwana Y; Kodaira H; Tanaka T; Maruyama N; Nozawa S; Horikoshi A; Takeuchi J
Hemodial Int; 2013 Jan; 17(1):133-5. PubMed ID: 22742581
[No Abstract] [Full Text] [Related]
35. Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.
Koens L; Senff NJ; Vermeer MH; Ronday HK; Willemze R; Jansen PM
Acta Derm Venereol; 2009 Nov; 89(6):653-4. PubMed ID: 19997706
[No Abstract] [Full Text] [Related]
36. Etanercept: an evolving role in psoriasis and psoriatic arthritis.
Prodanovich S; Ricotti C; Glick BP; Inverardi L; Leonardi CL; Kerdel F
Am J Clin Dermatol; 2010; 11 Suppl 1():3-9. PubMed ID: 20586498
[TBL] [Abstract][Full Text] [Related]
37. Etanercept, anticytokines and mania.
Kaufman KR
Int Clin Psychopharmacol; 2005 Jul; 20(4):239-41. PubMed ID: 15933486
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.
Sterry W; Ortonne JP; Kirkham B; Brocq O; Robertson D; Pedersen RD; Estojak J; Molta CT; Freundlich B
BMJ; 2010 Feb; 340():c147. PubMed ID: 20124563
[TBL] [Abstract][Full Text] [Related]
39. Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set.
FitzGerald O; Helliwell P; Mease P; Mumtaz A; Coates L; Pedersen R; Nab H; Molta C
Ann Rheum Dis; 2012 Mar; 71(3):358-62. PubMed ID: 21989542
[TBL] [Abstract][Full Text] [Related]
40. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.
Genovese MC; Cohen S; Moreland L; Lium D; Robbins S; Newmark R; Bekker P;
Arthritis Rheum; 2004 May; 50(5):1412-9. PubMed ID: 15146410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
